Prescription to over-the-counter switches: the physician perspective
Changes in a drug's availability from prescription only to over-the-counter (OTC) status is of concern to physicians from both public health and individual patient perspectives. While acknowledging the potential benefits of these switches, the author notes important caveats, including the need...
Gespeichert in:
| Veröffentlicht in: | Clinical therapeutics 1998, Vol.20, p.C118-C123 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | C123 |
|---|---|
| container_issue | |
| container_start_page | C118 |
| container_title | Clinical therapeutics |
| container_volume | 20 |
| creator | Byrns, Patricia J. |
| description | Changes in a drug's availability from prescription only to over-the-counter (OTC) status is of concern to physicians from both public health and individual patient perspectives. While acknowledging the potential benefits of these switches, the author notes important caveats, including the need for scientifically derived pediatric dosages; information in the medical record regarding OTC use that allows cohesive monitoring; clarity and precision in labeling for consumers; and continued coverage of such drugs for medically indigent patient populations. Current actions by physician organizations are noted. |
| doi_str_mv | 10.1016/S0149-2918(98)80016-7 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69139573</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0149291898800167</els_id><sourcerecordid>69139573</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-9ff186e0967395e5467246f7967da1e0d7565fa384d2b7d240e41494f9fbe9763</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMotVZ_QmFPoodosptNNl5E6icUFFTwFrbZCY20mzVJK_33ph_06mmYmXfmnXkQGlJyRQnl1--EMolzSasLWV1WJNWwOEB9WgmJKWVfh6i_lxyjkxC-CSGFLPMe6klJSyKrPrp_8xC0t120rs2iy9wSPI5TwNot2gg-C7826imEmyxVs266Clbbus068KEDHe0STtGRqWcBznZxgD4fHz5Gz3j8-vQyuhtjXXASsTSGVhyI5CKdASXjImfciJQ3NQXSiJKXpi4q1uQT0eSMAEsPMCPNBKTgxQCdb_d23v0sIEQ1t0HDbFa34BZBcUnTYlEkYbkVau9C8GBU5-289itFiVrTUxt6ao1GyUpt6CmR5oY7g8VkDs1-aocr9W-3fUhfLi14FbSFVkNjfUKhGmf_cfgDThl-_Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69139573</pqid></control><display><type>article</type><title>Prescription to over-the-counter switches: the physician perspective</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Byrns, Patricia J.</creator><creatorcontrib>Byrns, Patricia J.</creatorcontrib><description>Changes in a drug's availability from prescription only to over-the-counter (OTC) status is of concern to physicians from both public health and individual patient perspectives. While acknowledging the potential benefits of these switches, the author notes important caveats, including the need for scientifically derived pediatric dosages; information in the medical record regarding OTC use that allows cohesive monitoring; clarity and precision in labeling for consumers; and continued coverage of such drugs for medically indigent patient populations. Current actions by physician organizations are noted.</description><identifier>ISSN: 0149-2918</identifier><identifier>EISSN: 1879-114X</identifier><identifier>DOI: 10.1016/S0149-2918(98)80016-7</identifier><identifier>PMID: 9915098</identifier><language>eng</language><publisher>United States: EM Inc USA</publisher><subject>American Medical Association ; Attitude of Health Personnel ; benefit coverage ; Consumer Behavior ; drug labeling ; Drug Prescriptions ; Humans ; Nonprescription Drugs ; OTC ; Patient Education as Topic ; pediatric dosages ; Physicians ; United States</subject><ispartof>Clinical therapeutics, 1998, Vol.20, p.C118-C123</ispartof><rights>1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-9ff186e0967395e5467246f7967da1e0d7565fa384d2b7d240e41494f9fbe9763</citedby><cites>FETCH-LOGICAL-c360t-9ff186e0967395e5467246f7967da1e0d7565fa384d2b7d240e41494f9fbe9763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0149-2918(98)80016-7$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,4010,27904,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9915098$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Byrns, Patricia J.</creatorcontrib><title>Prescription to over-the-counter switches: the physician perspective</title><title>Clinical therapeutics</title><addtitle>Clin Ther</addtitle><description>Changes in a drug's availability from prescription only to over-the-counter (OTC) status is of concern to physicians from both public health and individual patient perspectives. While acknowledging the potential benefits of these switches, the author notes important caveats, including the need for scientifically derived pediatric dosages; information in the medical record regarding OTC use that allows cohesive monitoring; clarity and precision in labeling for consumers; and continued coverage of such drugs for medically indigent patient populations. Current actions by physician organizations are noted.</description><subject>American Medical Association</subject><subject>Attitude of Health Personnel</subject><subject>benefit coverage</subject><subject>Consumer Behavior</subject><subject>drug labeling</subject><subject>Drug Prescriptions</subject><subject>Humans</subject><subject>Nonprescription Drugs</subject><subject>OTC</subject><subject>Patient Education as Topic</subject><subject>pediatric dosages</subject><subject>Physicians</subject><subject>United States</subject><issn>0149-2918</issn><issn>1879-114X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhoMotVZ_QmFPoodosptNNl5E6icUFFTwFrbZCY20mzVJK_33ph_06mmYmXfmnXkQGlJyRQnl1--EMolzSasLWV1WJNWwOEB9WgmJKWVfh6i_lxyjkxC-CSGFLPMe6klJSyKrPrp_8xC0t120rs2iy9wSPI5TwNot2gg-C7826imEmyxVs266Clbbus068KEDHe0STtGRqWcBznZxgD4fHz5Gz3j8-vQyuhtjXXASsTSGVhyI5CKdASXjImfciJQ3NQXSiJKXpi4q1uQT0eSMAEsPMCPNBKTgxQCdb_d23v0sIEQ1t0HDbFa34BZBcUnTYlEkYbkVau9C8GBU5-289itFiVrTUxt6ao1GyUpt6CmR5oY7g8VkDs1-aocr9W-3fUhfLi14FbSFVkNjfUKhGmf_cfgDThl-_Q</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>Byrns, Patricia J.</creator><general>EM Inc USA</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1998</creationdate><title>Prescription to over-the-counter switches: the physician perspective</title><author>Byrns, Patricia J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-9ff186e0967395e5467246f7967da1e0d7565fa384d2b7d240e41494f9fbe9763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>American Medical Association</topic><topic>Attitude of Health Personnel</topic><topic>benefit coverage</topic><topic>Consumer Behavior</topic><topic>drug labeling</topic><topic>Drug Prescriptions</topic><topic>Humans</topic><topic>Nonprescription Drugs</topic><topic>OTC</topic><topic>Patient Education as Topic</topic><topic>pediatric dosages</topic><topic>Physicians</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Byrns, Patricia J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Byrns, Patricia J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prescription to over-the-counter switches: the physician perspective</atitle><jtitle>Clinical therapeutics</jtitle><addtitle>Clin Ther</addtitle><date>1998</date><risdate>1998</risdate><volume>20</volume><spage>C118</spage><epage>C123</epage><pages>C118-C123</pages><issn>0149-2918</issn><eissn>1879-114X</eissn><abstract>Changes in a drug's availability from prescription only to over-the-counter (OTC) status is of concern to physicians from both public health and individual patient perspectives. While acknowledging the potential benefits of these switches, the author notes important caveats, including the need for scientifically derived pediatric dosages; information in the medical record regarding OTC use that allows cohesive monitoring; clarity and precision in labeling for consumers; and continued coverage of such drugs for medically indigent patient populations. Current actions by physician organizations are noted.</abstract><cop>United States</cop><pub>EM Inc USA</pub><pmid>9915098</pmid><doi>10.1016/S0149-2918(98)80016-7</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0149-2918 |
| ispartof | Clinical therapeutics, 1998, Vol.20, p.C118-C123 |
| issn | 0149-2918 1879-114X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69139573 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | American Medical Association Attitude of Health Personnel benefit coverage Consumer Behavior drug labeling Drug Prescriptions Humans Nonprescription Drugs OTC Patient Education as Topic pediatric dosages Physicians United States |
| title | Prescription to over-the-counter switches: the physician perspective |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T09%3A29%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prescription%20to%20over-the-counter%20switches:%20the%20physician%20perspective&rft.jtitle=Clinical%20therapeutics&rft.au=Byrns,%20Patricia%20J.&rft.date=1998&rft.volume=20&rft.spage=C118&rft.epage=C123&rft.pages=C118-C123&rft.issn=0149-2918&rft.eissn=1879-114X&rft_id=info:doi/10.1016/S0149-2918(98)80016-7&rft_dat=%3Cproquest_cross%3E69139573%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69139573&rft_id=info:pmid/9915098&rft_els_id=S0149291898800167&rfr_iscdi=true |